Virtual Event Coverage

NobleCon19

December 3-5, 2023 - Boca Raton, Florida
InvestorBrandNetwork > Events > NobleCon19
NobleCon19

Now in its 19th year, NobleCon is widely recognized as the preeminent showcase of emerging growth companies. With over 100 executive teams and scores of potential investors ranging from institutions, brokers and family offices, to interested, self-directed individuals, NobleCon is an interactive business environment like few others.

For more information visit:
Conference Website

AdTheorent Holding Company Inc. (NASDAQ: ADTH)

AdTheorent Holding Co Inc. (NASDAQ: ADTH) is a digital media platform that focuses on performance-first, privacy-forward methods to execute programmatic digital advertising campaigns, serving both advertising agency and brand customers. Geographically it serves Canada, the United Kingdom and Others. Key revenue is earned from the United States. For more information, visit the company's website at: adtheorent.com

Aeterna Zentaris Inc. (NASDAQ: AEZS)

Aeterna Zentaris Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company's lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macimorelin is currently marketed in the United States under the tradename Macrilen ™ through a license agreement with Novo Nordisk where Aeterna Zentaris receives royalties on sales. According to a commercialization and supply agreement, MegaPharm Ltd. will seek regulatory approval and then commercialize macimorelin in Israel and the Palestinian Authority. Additionally, upon receipt of pricing and reimbursement approvals, Aeterna expects that macimorelin will be marketed in Europe and the United Kingdom through a recently established license agreement with Consilient Health Ltd and Aeterna Zentaris will receive royalties on sales and other potential payments. Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD), an area of significant unmet need. The Company is actively pursuing business development opportunities for the commercialization of macimorelin in Asia and the rest of the world, in addition to other non-strategic assets to monetize their value. For more information, visit the company's website at: www.zentaris.com

AIM ImmunoTech Inc. (NYSE American: AIM)

AIM ImmunoTech Inc. (NYSE American: AIM) is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. For more information, visit the company's website at: www.aimimmuno.com

Alico Inc. (NASDAQ: ALCO)

Alico Inc. (NASDAQ: ALCO) is a Florida agribusiness and land management company. It manages its land-based upon its primary usage and reviews its performance based upon two primary classifications – Alico Citrus and Conservation and Water Resources and Other Operations. The company derives most of its revenues from the Alico Citrus segment. For more information, visit the company's website at: www.alicoinc.com

Alliance Resource Partners L.P. (NASDAQ: ARLP)

Alliance Resource Partners L.P. (NASDAQ: ARLP) is a diversified energy company that is currently the largest coal producer in the Eastern United States. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast-growing energy and infrastructure transition. For more information, visit the company's website at: www.arlp.com

aTyr Pharma Inc. (NASDAQ: LIFE)

aTyr Pharma Inc. (NASDAQ: LIFE) is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology. It has discovered approximately 300 Physiocrines, a class of naturally occurring human proteins that it promotes homeostasis, a fundamental process of restoring stressed or diseased tissue to a healthier state. The company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component. Business activity is primarily conducted through the United States. For more information, visit the company's website at: atyrpharma.com

AZZ Inc. (NYSE: AZZ)

AZZ Inc. (NYSE: AZZ) is North America's leading independent provider of hot-dip galvanizing and coil coating solutions to a broad range of end-markets. The Company's Metal Coatings segment is a leading provider of metal finishing solutions for corrosion protection, including hot-dip galvanizing, spin galvanizing, powder coating, anodizing and plating to the steel fabrication industry. The AZZ Precoat Metals segment provides aesthetic and corrosion protective coatings and related value-added services for steel and aluminum coil, primarily serving the construction; appliance; heating, ventilation, and air conditioning (HVAC); container; transportation and other end markets in the United States. Collectively, the Company's business segments provide sustainable, unmatched metal coating solutions that enhance the longevity and appearance of buildings, products and infrastructure that are essential to everyday life. For more information, visit the company's website at: www.azz.com

Baudax Bio Inc. (NASDAQ: BXRX)

Baudax Bio Inc. (NASDAQ: BXRX) is a pharmaceutical company focused on innovative products for acute care settings. Baudax Bio markets ANJESO®, the first and only 24-hour, non-opioid, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO®, the Company has a pipeline of other innovative pharmaceutical assets including two clinical-stage, novel neuromuscular blocking (NMBs) agents and a proprietary chemical reversal agent specific to these NMBs. For more information, visit the company's website at: www.baudaxbio.com

Beasley Broadcast Group Inc. (NASDAQ: BBGI)

Beasley Broadcast Group Inc. (NASDAQ: BBGI) owns and operates 61 stations (47 FM and 14 AM) in 14 large- and mid-size markets in the United States. Approximately 20 million consumers listen to the Company's radio stations weekly over-the-air, online and on smartphones and tablets, and millions regularly engage with the Company's brands and personalities through digital platforms such as Facebook, Twitter, text messaging, digital and web applications and email. The Overwatch League's Houston Outlaws esports team is a wholly owned subsidiary. The Company also owns BeasleyXP, a national esports content hub, and AXLR-R8, a Rocket League Championship Series team, in its esports portfolio. For more information, visit the company's website at: www.bbgi.com

Bit Digital Inc. (NASDAQ: BTBT)

Bit Digital (NASDAQ: BTBT) is a sustainability focused generator of digital assets. Headquartered in New York, Bit Digital has a large-scale bitcoin mining business with operations across the U.S. and Canada. The Company also acts as a validator on the Ethereum network. For more information, visit the company's website at: bit-digital.com

Bitcoin Depot Inc. (NASDAQ: BTM)

Bitcoin Depot Inc. (NASDAQ: BTM) was founded in 2016 with the mission to connect those who prefer to use cash to the broader, digital financial system. Bitcoin Depot provides its users with simple, efficient and intuitive means of converting cash into Bitcoin, which users can deploy in the payments, spending and investing space. Users can convert cash to Bitcoin at Bitcoin Depot's kiosks and at thousands of name-brand retail locations through its BDCheckout product. Bitcoin Depot has the largest market share in North America with approximately 6,400 kiosk locations as of June 30, 2023. For more information, visit the company's website at: www.bitcoindepot.com

Cadrenal Therapeutics Inc. (NASDAQ: CVKD)

Cadrenal Therapeutics Inc. (NASDAQ: CVKD) is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. For more information, visit the company's website at: www.cadrenal.com

Can-Fite Biopharma Ltd (NYSE AMERICAN: CANF)

Can-Fite Biopharma Ltd (NYSE AMERICAN: CANF) is a clinical-stage biopharmaceutical company. The company is focused on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune inflammatory indications, oncology and liver diseases as well as sexual dysfunction. Its platform technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention. The company's pipeline drugs are synthetic, specific agonists and allosteric modulators targeting the A3AR. All drugs are orally bioavailable with an excellent safety profile. For more information, visit the company's website at: www.canfite.com

Citius Pharmaceuticals Inc. (NASDAQ: CTXR)

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments. For more information, visit the company's website at: www.citiuspharma.com

Cocrystal Pharma Inc. (NASDAQ: COCP)

Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For more information, visit the company's website at: www.cocrystalpharma.com

Collective Mining Ltd (OTCQX: CNLMF)

Collective Mining Ltd (OTCQX: CNLMF) is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. Founded by the team that developed and sold Continental Gold Inc. to Zijin Mining for approximately $2 billion in enterprise value, the mission of the Company is to repeat its past success in Colombia by making a significant new mineral discovery and advancing the projection to production. Management, insiders and close family and friends own approximately 40% of the outstanding shares of the Company and as a result, are fully aligned with shareholders. Collective currently holds an option to earn up to a 100% interest in two projects located in Colombia. As a result of an aggressive exploration program at both the Guayabales and San Antonio projects a total of eleven major targets have been defined. The Company is fortuitous to have made significant grassroots discoveries on both projects with discovery holes of 302 metres 1.1 g/t AuEq and 104 metres @ 1.3 g/t AuEq at the Guayabales project and 710 metres @ 0.53 AuEq at the San Antonio project. For more information, visit the company's website at: www.collectivemining.com

Commercial Vehicle Group Inc. (NASDAQ: CVGI)

Commercial Vehicle Group Inc. (NASDAQ: CVGI) is a supplier of cab related products and systems. The operating segments are The Electrical Systems Segment and The Global Seating Segment. The Global Seating Segment manufactures and sells products, such as seats, Office seatings. The Electrical Systems Segment is engaged in electronic wire harness assemblies and trim systems and components. The company supplies products to the various vehicle markets, which include medium-and heavy-construction vehicle market, military, bus, agriculture, mining, industrial equipment and off-road recreational markets. Geographically, it operates through the United States and it also has a business presence internationally. For more information, visit the company's website at: cvgrp.com

Comtech Telecommunications Corp. (NASDAQ: CMTL)

Comtech Telecommunications Corp. (NASDAQ: CMTL) is a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies to commercial and government customers around the world. Headquartered in Melville, New York and with a passion for customer success, Comtech designs, produces and markets advanced and secure wireless solutions. For more information, visit the company's website at: www.comtech.com

CRA International Inc. (NASDAQ: CRAI)

CRA International, Inc. (NASDAQ: CRAI) is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings, and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. In addition, CRA International owns a majority stake in NeuCo, a company that develops and markets neutral network software tools and related application consultancy services. CRA International generates almost all its revenue from the United States and United Kingdom. For more information, visit the company's website at: www.crai.com

Cumulus Media Inc. (NASDAQ: CMLS)

Cumulus Media Inc. (NASDAQ: CMLS) is an audio-first media company delivering premium content to over a quarter billion people every month — wherever and whenever they want it. Cumulus Media engages listeners with high-quality local programming through 405 owned-and-operated radio stations across 86 markets; delivers nationally-syndicated sports, news, talk, and entertainment programming from iconic brands including the NFL, the NCAA, the Masters, CNN, the AP, the Academy of Country Music Awards, and many other world-class partners across more than 9,500 affiliated stations through Westwood One, the largest audio network in America; and inspires listeners through the Cumulus Podcast Network, its rapidly growing network of original podcasts that are smart, entertaining and thought-provoking. Cumulus Media provides advertisers with personal connections, local impact and national reach through broadcast and on-demand digital, mobile, social, and voice-activated platforms, as well as integrated digital marketing services, powerful influencers, full-service audio solutions, industry-leading research and insights, and live event experiences. Cumulus Media is the only audio media company to provide marketers with local and national advertising performance guarantees. For more information, visit the company's website at: www.cumulusmedia.com

Daktronics Inc. (NASDAQ: DAKT)

Daktronics Inc. (NASDAQ: DAKT) designs and manufactures electronic scoreboards, programmable display systems and large screen video displays for sporting, commercial and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. For more information, visit the company's website at: www.daktronics.com

DigitalBridge Group Inc. (NYSE: DBRG)

DigitalBridge Group Inc is a global digital infrastructure real estate investment trust that owns, operates, and invests in digital infrastructure and real estate. Previously Colony Capital, the firm merged with its subsidiary Digital Colony in 2020 to rebrand as DigitalBridge. This merger discontinued ownership of hospitality real estate and shifted focus toward digital infrastructure. Its services occupy three segments: Digital Investment Management, Digital Operating, and Corporate and Other. The Digital Operating segment, which owns and leases digital assets, accounts for the majority of the firm's revenue from markets primarily located in the United States. For more information, visit the company's website at: www.digitalbridge.com

Direct Digital Holdings Inc. (NASDAQ: DRCT)

Direct Digital Holdings (NASDAQ: DRCT), owner of operating companies Colossus SSP, Huddled Masses, and Orange 142, brings state-of-the-art sell- and buy-side advertising platforms together under one umbrella company. Direct Digital Holdings' sell-side platform, Colossus SSP, offers advertisers of all sizes extensive reach within general market and multicultural media properties. The company's subsidiaries Huddled Masses and Orange142 deliver significant ROI for middle market advertisers by providing data-optimized programmatic solutions at scale for businesses in sectors that range from energy to healthcare to travel to financial services. Direct Digital Holdings' sell- and buy-side solutions manage approximately 90,000 clients monthly, generating over 100 billion impressions per month across display, CTV, in-app and other media channels. The company has been named a top minority-owned business by The Houston Business Journal. For more information, visit the company's website at: directdigitalholdings.com

Draganfly Inc. (NASDAQ: DPRO)

Draganfly Inc. (NASDAQ: DPRO) is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. It generates revenue through Product sales and Consulting. Product sales revenue consists of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Consulting service includes custom engineering and training and simulation consulting. For more information, visit the company's website at: draganfly.com

Dyadic International Inc. (NASDAQ: DYAI)

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the industrially proven hyper productive engineered fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles (VLPs) and antigens, monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and improve access and cost to patients and the healthcare system, but most importantly save lives. For more information, visit the company's website at: dyadic.com

Eledon Pharmaceuticals (NASDAQ: ELDN)

Eledon Pharmaceuticals (NASDAQ: ELDN) is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company's lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, California. For more information, visit the company's website at: www.eledon.com

Entravision Communications Corporation (NYSE: EVC)

Entravision Communications Corporation (NYSE: EVC) is a diversified Spanish-language media company utilizing a combination of television and radio operations to reach Hispanic consumers across the United States, as well as the border markets of Mexico. Entravision owns and/or operates 53 primary television stations and is the largest affiliate group of both the top-ranked Univision television network and Univision's TeleFutura network, with television stations in 20 of the nation's top 50 Hispanic markets. The Company also operates one of the nation's largest groups of primarily Spanish-language radio stations, consisting of 48 owned and operated radio stations. For more information, visit the company's website at: entravision.com

FAT Brands Inc. (NASDAQ: FAT)

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets and develops fast casual and casual dining restaurant concepts around the world. The Company currently owns nine restaurant brands: Fatburger, Johnny Rockets, Buffalo's Cafe, Buffalo's Express, Hurricane Grill & Wings, Elevation Burger, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises approximately 700 units worldwide. For more information, visit the company's website at: www.fatbrands.com

FPX Nickel Corp. (TSX-V: FPX) (OTCQB: FPOCF)

FPX Nickel Corp. (TSX-V: FPX) (OTCQB: FPOCF) is a Canada-based mineral exploration company. The company is involved in the acquisition and exploration of mineral property interests. It operates in the exploration of mineral properties segment. The Decar project, which is the company's flagship nickel property, is a greenfield discovery of nickel mineralization in the form of a naturally occurring nickel-iron alloy called awaruite. For more information, visit the company's website at: fpxnickel.com

Geovax Labs (NASDAQ: GOVX)

GeoVax Labs, Inc. (NASDAQ: GOVX) is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in two Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a COVID-19 vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient. In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information, visit the company's website at: www.geovax.com

GoHealth Inc. (NASDAQ: GOCO)

GoHealth Inc. (NASDAQ: GOCO) is a health insurance marketplace in America. Its technology platform leverages modern machine-learning algorithms and helps individuals find the best health insurance plan for their specific needs. The company operates in four segments: Medicare-Internal; Medicare-External, IFP and Other-Internal; and IFP and Other-External. The Medicare segments sales Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans. For more information, visit the company's website at: www.gohealth.com

Graham Corporation (NYSE: GHM)

Graham Corporation (NYSE: GHM) manufactures and sells critical equipment for the energy, defense and chemical/petrochemical industries based with emphasis on the United States. Its suite of products includes ejectors, surface condensers, and liquid vacuum pumps. For the defense industry, its equipment is used in nuclear propulsion power systems for the U.S. Navy. For the chemical and petrochemical industries, its equipment is used in fertilizer, ethylene, methanol and downstream chemical facilities. The company derives its revenue from the sale of heat transfer equipment. For more information, visit the company's website at: grahamcorp.com

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD)

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 132-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company's Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company's culture. The Company's commitment to the IIF® culture promotes a work environment where employee safety is paramount. For more information, visit the company's website at: gldd.com

Greenland Technologies Holding Corporation (NASDAQ: GTEC)

Greenland Technologies Holding Corp. (NASDAQ: GTEC) is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. The company sold more than 108000 sets of transmission systems to over 100 forklift manufacturers in China. With the emphasis on quality and innovation, over the years, Greenland gained the trust and loyalty from its customers. For more information, visit the company's website at: ir.gtec-tech.com

Helius Medical Technologies Inc. (NASDAQ: HSDT)

Helius Medical Technologies Inc. (NASDAQ: HSDT) is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain's ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company's first commercial product is the Portable Neuromodulation Stimulator. For more information, visit the company's website at: www.heliusmedical.com

Hemisphere Energy Corp (OTCQX: HMENF)

Hemisphere Energy Corp (OTCQX: HMENF) is a Canadian oil company focused on sustainable growth of its high netback, low decline conventional heavy oil assets through water and polymer flood enhanced recovery methods. It specializes in the development of conventional oil pools using enhanced oil recovery methods such as waterflood and polymer flood to maximize production and oil recovery. The company's oil assets are in Manville oil play in the Atlee Buffalo and Jenner areas of southeastern Alberta. For more information, visit the company's website at: www.hemisphereenergy.ca

Hoth Therapeutics Inc. (NASDAQ: HOTH)

Hoth Therapeutics Inc. (NASDAQ: HOTH) is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups. For more information, visit the company's website at: hoththerapeutics.com

Information Services Group Inc. (NASDAQ: III)

Information Services Group Inc. (NASDAQ: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 70 of the top 100 enterprises in the world, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry's most comprehensive marketplace data. For more information, visit the company's website at: www.isg-one.com

InPlay Oil (TSX: IPO) (OTCQX: IPOOF)

InPlay Oil is a junior oil and gas exploration and production company with operations in Alberta focused on light oil production. The Company operates long-lived, low-decline properties with drilling development and enhanced oil recovery potential as well as undeveloped lands with exploration possibilities. The Common Shares on the Toronto Stock Exchange under the symbol IPO and the OTCQX under the symbol IPOOF. For more information, visit the company's website at: www.inplayoil.com

Inspire Veterinary Partners Inc. (NASDAQ: IVP)

Inspire Veterinary Partners, Inc. (NASDAQ: IVP) owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds. Services provided at the Company¿s hospitals include preventive care for companion animals consisting of annual health exams that include parasite control, dental health, nutrition and body condition counseling, neurological examinations, radiology, bloodwork, skin and coat health, and many breed-specific preventive care services. Surgical offerings include all soft tissue procedures such as spays and neuters, mass removals, splenectomies and also include gastropexies, orthopedic procedures, and other types of surgical offerings based on a doctor¿s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic, and various other health and wellness offerings. For more information, visit the company's website at: www.inspirevet.com

Jaguar Health Inc. (NASDAQ: JAGX)

Jaguar Health Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. It operates into two business segments namely Humal health and animal health. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. jaguar.health

Jushi Holdings Inc. (OTCQX: JUSHF)

Jushi Holdings Inc. (OTCQX: JUSHF) is a vertically integrated, multi‑state cannabis company engaged in developing and operating high-end retail locations, premium brands, and state-of-the-art cultivation, manufacturing, and processing facilities in both medical and adult‑use markets. The Company is focused on building a diverse portfolio of cannabis assets through opportunistic investments, acquisitions, and pursuing application opportunities in attractive limited license markets. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. The Company has targeted assets in highly populated, limited licensed medical markets with a trajectory toward adult-use legalization and limited license, fast-growing, large adult-use markets. Operating under the Jushi umbrella is the Beyond Hello, Nature's Remedy, and NuLeaf retail brands of cannabis dispensaries. For more information, visit the company's website at: jushico.com

Kelly Services Inc. (NASDAQ: KELYA; KELYB)

Kelly Services, Inc. (NASDAQ: KELYA; KELYB) connects talented people to companies in need of their skills in areas including Science, Engineering, Education, Office, Contact Center, Light Industrial, and more. We're always thinking about what's next in the evolving world of work, and they help people ditch the script on old ways of thinking and embrace the value of all workstyles in the workplace. Kelly Services directly employs more than 350,000 people around the world, and they connect thousands more with work through their global network of talent suppliers and partners in their outsourcing and consulting practice. Revenue in 2021 was $4.9 billion. For more information, visit the company's website at: kellyservices.com

Lakeland Industries Inc. (NASDAQ: LAKE)

Lakeland Industries Inc. (NASDAQ: LAKE) manufactures and sells safety garments and accessories for industrial protective clothing market. It offers limited use / disposable protective clothing, chemical protective suits, and firefighting and heat protective apparel. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, mortuaries, as well as scientific and medical laboratories. The company made its sales to more than 40 foreign countries but primarily in China, European Economic Community, Canada, Chile, Argentina, Russia, Colombia, Mexico, Ecuador, Australia and Southeast Asia. It derives the sales primarily from the sale of limited use/disposable protective clothing. For more information, visit the company's website at: www.lakeland.com

Lisata Therapeutics Inc. (NASDAQ: LSTA)

Lisata Therapeutics Inc. (NASDAQ: LSTA) is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata's lead product candidate, LSTA1, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively. Based on Lisata's CendR Platform® Technology, Lisata has already established noteworthy commercial and R&D partnerships. The Company expects to announce numerous clinical study and business milestones over the next two years and has projected that its current business and development plan is funded with available capital through these milestones and into early 2026. For more information, visit the company's website at: www.lisata.com

MAIA Biotechnology Inc. (NYSE American: MAIA)

MAIA Biotechnology Inc. (NYSE American: MAIA) is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Their lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, visit the company's website at: www.maiabiotech.com

Newrange Gold Corp. (TSXV: NRG)

Newrange Gold Corp. (TSXV: NRG) has signed a non-binding term sheet for an RTO with ASX-listed Mithril Resources to create a new Americas-focused precious metals exploration & development company. The flagship project will be the high-grade gold-silver Copalquin Project in the Sierra Madre of Mexico. The Company will also continue to focus on district-scale exploration for precious metals in the prolific Red Lake District of northwestern Ontario. The past-producing high-grade Argosy Gold Mine is open to depth, while the adjacent North Birch Project offers additional blue-sky potential. Both projects lie within 10-12 kilometres of the Springpole Gold Deposit currently under development by First Mining Gold. For more information, visit the company's website at: newrangegold.com

Ocugen, Inc. (NASDAQ: OCGN)

Ocugen, Inc. (NASDAQ: OCGN) is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. They are making an impact on patient's lives through courageous innovation—forging new scientific paths that harness their unique intellectual and human capital. Their breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and they are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. ocugen.com

Onconova Therapeutics Inc. (NASDAQ: ONTX)

Onconova Therapeutics Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor narazaciclib (formerly ON 123300) is being evaluated in a combination trial with estrogen blockade in advanced endometrial cancer. Based on preclinical and clinical studies of CDK 4/6 inhibitors, Onconova is also evaluating opportunities for combination studies with narazaciclib in additional indications. Onconova's product candidate rigosertib is being studied in multiple investigator-sponsored studies. These studies include a dose-escalation and expansion Phase 1/2a study of oral rigosertib in combination with nivolumab in patients with KRAS+ non-small cell lung cancer, a Phase 2 program evaluating rigosertib monotherapy in advanced squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa (RDEB-associated SCC), and a Phase 2 trial evaluating rigosertib in combination with pembrolizumab in patients with metastatic melanoma. For more information, visit the company's website at: www.onconova.com

One Stop Systems Inc. (NASDAQ: OSS)

One Stop Systems, Inc. (NASDAQ: OSS) designs and manufactures innovative AI Transportable edge computing modules and systems, including ruggedized servers, compute accelerators, expansion systems, flash storage arrays, and Ion Accelerator™ SAN, NAS, and data recording software for AI workflows. These products are used for AI data set capture, training, and large-scale inference in the defense, oil and gas, mining, autonomous vehicles, and rugged entertainment applications. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for industrial OEMs and government customers. The company enables AI on the Fly® by bringing AI datacenter performance to 'the edge,' especially on mobile platforms, and by addressing the entire AI workflow, from high-speed data acquisition to deep learning, training, and inference. OSS products are available directly or through global distributors. For more information, visit the company's website at: www.onestopsystems.com

Orion Group Holdings Inc. (NYSE: ORN)

Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. The Company's marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices throughout its operating areas. For more information, visit the company's website at: www.oriongroupholdingsinc.com

PDS Biotechnology Corporation (NASDAQ: PDSB)

PDS Biotechnology Corporation (NASDAQ: PDSB) is a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer and infectious disease immunotherapies based on their proprietary Versamune® and Infectimune™ T cell-activating technology platforms. They believe their targeted Versamune® based candidates have the potential to overcome the limitations of current immunotherapy by inducing large quantities of high-quality, potent polyfunctional tumor specific CD4+ helper and CD8+ killer T cells. To date, their lead Versamune® clinical candidate, PDS0101, has demonstrated the potential to reduce tumors and stabilize disease in combination with approved and investigational therapeutics in patients with a broad range of HPV-positive cancers in multiple Phase 2 clinical trials. Their Infectimune™ based vaccines have also demonstrated the potential to induce not only robust and durable neutralizing antibody responses, but also powerful T cell responses, including long-lasting memory T cell responses in pre-clinical studies to date. For more information, visit the company's website at: www.pdsbiotech.com

PodcastOne Inc. (NASDAQ: PODC)

PodcastOne Inc. (NASDAQ: PODC) is a Los Angeles based podcast network founded in 2012 by Kit Gray and Norm Pattiz providing creators and advertisers with a full 360-degree solution in sales, marketing, public relations, production, and distribution delivering over 2.1 billion downloads per year with a community of 250 of the top podcasters, including Adam Carolla, Kaitlyn Bristowe, Jordan Harbinger, LadyGang, and A&E's Cold Case Files. PodcastOne has built a distribution network reaching over 1 billion listeners a month across all of its own properties, LiveOne (Nasdaq: LVO), Spotify, Apple Podcasts, iHeartRadio, Samsung and over 150 shows exclusively available in Tesla vehicles. PodcastOne is also the parent company of LaunchpadOne, an innovative self-serve platform developed to launch, host, distribute and monetize independent user-generated podcasts.For more information, visit the company's website at: podcastone.com

PSQ Holdings Inc. (NYSE: PSQH)

PSQ Holdings, Inc. (NYSE: PSQH) is an app and website that connects patriotic Americans to high-quality businesses that share their values, both online and in their local communities. The primary mission of the platform is to help consumers "shop their values" and put purpose behind their purchases. In just over one year since its nationwide launch, PublicSquare has seen tremendous growth and proven to the nation that the parallel, "patriotic" economy can be a major force in commerce. The platform has over 70,000 businesses from a variety of different industries and roughly 1.6 million consumer members. Additionally, PublicSquare leverages data and insights from the platform to assess its members' needs and provide quality wholly-owned products, such as EveryLife diapers and wipes, to fill those needs. PublicSquare is free to join for both consumers and business owners alike. For more information, visit the company's website at: www.publicsquare.com

Quantum Computing Inc. (NASDAQ: QUBT)

Quantum Computing Inc. (NASDAQ: QUBT), a first-to-market nanophotonic-based quantum technology company offers real-world, affordable commercial applications. QCi delivers democratized quantum solutions at greater speed and accuracy, at room temperatures, with little training, low power and no unique environmental requirements. QCi's leverages its core technology throughout its product offerings of computing, sensing and imaging solutions. QCi's entropy computer, the Dirac, delivers solutions for binary (11,000+ qubits) and integer (1000+ qudits) optimization problems, the highest number of variables and problem size available in quantum computing today. QCi¿s quantum applications include Reservoir Photonic Computer (AI), cybersecurity, imaging, sensing (LiDAR), and QRNG products. For more information, visit the company's website at: www.quantumcomputinginc.com

Saga Communications Inc. (NASDAQ: SGA)

Saga Communications, Inc. (NASDAQ: SGA) is a broadcast company whose business is primarily devoted to acquiring, developing and operating radio stations. Saga currently owns or operates broadcast properties in 27 markets, including 79 FM and 33 AM radio stations. Saga's strategy is to operate top billing radio stations in mid sized markets, defined as markets ranked (by market revenues) from 20 to 200. Saga's radio stations employ a myriad of programming formats, including Active Rock, Adult Album Alternative, Adult Contemporary, Country, Classic Country, Classic Hits, Classic Rock, Contemporary Hits Radio, News/Talk, Oldies and Urban Contemporary. In operating its stations, Saga concentrates on the development of strong decentralized local management, which is responsible for the day-to-day operations of the stations in their market area and is compensated based on their financial performance as well as other performance factors that are deemed to effect the long-term ability of the stations to achieve financial objectives. Saga began operations in 1986 and became a publicly traded company in December 1992. The stock trades on NASDAQ under the ticker symbol "SGA"." For more information, visit the company's website at: sagacom.com

Salem Media Group Inc. (NASDAQ: SALM)

Salem Media Group Inc. (NASDAQ: SALM) is America's leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. For more information, visit the company's website at: salemmedia.com

Snail Inc. (NASDAQ: SNAL)

Snail Inc. (NASDAQ: SNAL) is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's and mobile devices. Geographic presence of company is in United States and International majority of its revenue comes from United States. For more information, visit the company's website at: snail.com

Terran Orbital Corporation (NYSE: LLAP)

Terran Orbital Corp. (NYSE: LLAP) is a vertically integrated provider of end-to-end satellite solutions. The company combines satellite design, production, launch planning, mission operations and in-orbit support to meet the needs of the demanding military, civil and commercial customers. In addition, Terran Orbital is developing the advanced NextGen Earth Observation constellation to provide persistent, real-time earth imagery. For more information, visit the company's website at: terranorbital.com

The E.W. Scripps Company (NASDAQ: SSP)

The E.W. Scripps Company (NASDAQ: SSP) is a diversified media company focused on creating a better-informed world. As the nation's fourth-largest local TV broadcaster, Scripps serves communities with quality, objective local journalism and operates a portfolio of 61 stations in 41 markets. Scripps' national networks reach nearly every American through the news outlets Court TV and Newsy and popular entertainment brands ION, Bounce, Grit, Laff and Court TV Mystery. Scripps is the nation's largest holder of broadcast spectrum. Scripps runs an award-winning investigative reporting newsroom in Washington, D.C., and is the longtime steward of the Scripps National Spelling Bee. Founded in 1878, Scripps has held for decades to the motto, "Give light and the people will find their own way." For more information, visit the company's website at: scripps.com

The GEO Group, Inc. (NYSE: GEO)

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees. For more information, visit the company's website at: www.geogroup.com

The ODP Corporation (NASDAQ: ODP)

The ODP Corporation (NASDAQ: ODP) is a leading provider of products, services, and technology solutions through an integrated business-to-business (B2B) distribution platform and omni-channel presence, which includes world-class supply chain and distribution operations, dedicated sales professionals, a B2B digital procurement solution, online presence, and a network of Office Depot and OfficeMax retail stores. Through its operating companies Office Depot, LLC; ODP Business Solutions, LLC; Veyer, LLC; and Varis, Inc, The ODP Corporation empowers every business, professional, and consumer to achieve more every day. For more information, visit the company's website at: theodpcorp.com

TLGY Acquisition Corporation (NASDAQ: TLGY)

TLGY Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. For more information, visit the company's website at: www.tlgyacquisition.com

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix's CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix's lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the second quarter of 2023. TNX-102 SL is also being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix initiated a Phase 2 study in Long COVID in the third quarter of 2022 and expects interim data in the first half of 2023. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the first quarter of 2023. TNX-1900 (intranasal potentiated oxytocin), a small molecule in development for chronic migraine, is expected to enter the clinic with a Phase 2 study in the fourth quarter of 2022. TNX-601 ER (tianeptine hemioxalate extended-release tablets) is a once-daily formulation of tianeptine being developed as a potential treatment for major depressive disorder (MDD) with a Phase 2 study expected to be initiated in the first quarter of 2023. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan Drug designation by the FDA. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the first half of 2023. Tonix's infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, next-generation vaccines to prevent COVID-19, and a platform to make fully human monoclonal antibodies to treat COVID-19. TNX-801, Tonix's vaccine in development to prevent smallpox and monkeypox, also serves as the live virus vaccine platform or recombinant pox vaccine (RPV) platform for other infectious diseases. A Phase 1 study of TNX-801 is expected to be initiated in Kenya in the first half of 2023. Tonix's lead vaccine candidate for COVID-19 is TNX-1850, a live virus vaccines based on Tonix's recombinant pox live virus vector vaccine platform. For more information, visit the company's website at: www.tonixpharma.com

Townsquare Media Inc. (NYSE: TSQ)

Townsquare Media Inc. (NYSE: TSQ) is an entertainment and media company offering digital marketing solutions in the United States and Canada. It owns and operates radio stations, social media properties focusing the small and mid-cap companies. Services offered to the clients include live events, local advertising, digital advertising, e-commerce offerings, few others. The segments through which the company operates its businesses are classified into Local marketing solutions and Entertainment segments. Revenues are generated from commercials through broadcasts and sale of internet based advertisements. For more information, visit the company's website at: www.townsquaremedia.com

Unicycive Therapeutics Inc. (NASDAQ: UNCY)

Unicycive Therapeutics Inc. (NASDAQ: UNCY) is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. For more information, visit the company's website at: unicycive.com

V2X Inc. (NYSE: VVX)

V2X Inc. (NYSE: VVX) is a leading provider of critical mission solutions and support to defense clients globally, formed by the 2022 merger of Vectrus and Vertex to build on more than 120 combined years of successful mission support. The Company delivers a comprehensive suite of integrated solutions across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. Their global team of approximately 14,000 employees brings innovation to every point in the mission lifecycle, from preparation, to operations, to sustainment, as they tackle the most complex challenges with agility, grit and dedication. For more information, visit the company's website at: gov2x.com

Zomedica Pharmaceuticals Corp. (NYSE American: ZOM)

Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. For more information, visit the company's website at: zomedica.com

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717